Comparison of Contrast Enhanced Digital Breast Tomosynthesis and Magnetic Resonance Imaging in Patients With Known Breast Lesions
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
The purpose of this pilot study is to compare radiologist confidence level in evaluating patients with known breast lesions between contrast enhanced digital breast tomosynthesis (CE- DBT) and contrast enhanced dynamic magnetic resonance imaging (CE-MRI) acquired as a part of a standard clinical workup.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Women at least 18 years old
• Planned or received conventional breast MRI at UNC Hospitals within 3 months prior to or after the research scan
• Suspected breast lesion based on prior imaging (BIRADS 4 or greater)
• Able to provide written informed consent
Locations
United States
North Carolina
University of North Carolina at Chapel Hill
RECRUITING
Chapel Hill
Contact Information
Primary
Carly Sronce, BSN, RN-BC
carly_sronce@med.unc.edu
919-966-3262
Backup
Doreen Steed, R.T.(R)(M)
doreen_steed@med.unc.edu
919-966-0188
Time Frame
Start Date: 2023-03-13
Estimated Completion Date: 2026-08-22
Participants
Target number of participants: 20
Treatments
Experimental: Contrast-enhanced digital breast tomosynthesis (CE-DBT)
Participants with known breast lesions will be imaged using contrast-enhanced digital breast tomosynthesis (CE-DBT) with Iohexol 350 mg I/mL.
Related Therapeutic Areas
Sponsors
Leads: UNC Lineberger Comprehensive Cancer Center